Apollo Hospitals offers a breast cancer risk assessment tool for Indian women to understand their risk and take proactive ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation to PreludeDx's DCISionRT test, a risk ...
Histopathological evaluation of tumor specimens has long been essential in diagnosing breast cancer and guiding clinical ...
Kicking things off with Olivia Munn’s breast cancer diagnosis. Last year, Inside Correspondent Alison Hall reported on Olivia ...
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...
Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...
Today, the National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers-published a new resource to inform people about the latest recommendations around hereditary and familial ...
Histopathological evaluation of tumour specimens has long been essential in diagnosing breast cancer and guiding clinical ...
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker ...
As evidence accumulates on the protective effects of a plant-heavy diet against cancers, experts explain how providers can ...